Short Interest in BioNxt Solutions Inc. (OTCMKTS:BNXTF) Increases By 60.0%

BioNxt Solutions Inc. (OTCMKTS:BNXTF) was the recipient of a significant growth in short interest during the month of November. As of November 15th, there was short interest totalling 1,600 shares, a growth of 60.0% from the October 31st total of 1,000 shares. Based on an average daily volume of 8,300 shares, the short-interest ratio is currently 0.2 days.

BioNxt Solutions Price Performance

OTCMKTS BNXTF traded down $0.02 during mid-day trading on Friday, reaching $0.18. 2,300 shares of the company’s stock traded hands, compared to its average volume of 14,040. BioNxt Solutions has a 1-year low of $0.11 and a 1-year high of $0.57. The company has a fifty day simple moving average of $0.18 and a 200-day simple moving average of $0.20.

BioNxt Solutions (OTCMKTS:BNXTF) last released its quarterly earnings data on Wednesday, August 28th. The company reported ($0.01) earnings per share for the quarter.

About BioNxt Solutions

BioNxt Solutions Inc engages in generation drug formulations and delivery system in Korea, Austria, Germany, and Switzerland. The company provides drug delivery methods, such as transdermal patches and oral dissolvable films designed for delivery of neurological medications. It offers point-of-care diagnostic, including covid-19 PCR diagnostic kit, a covid rapid test; peri-implantitis Oral Biosensor, allows early detection of infection associated with dental implants; and H1N1 (Swine Flu) and H5N1 (Avian Flu) oral biosensors for early detection of highly pathogenic influenza a strains.